Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03831386 · ClinicalTrials.gov registry record · NA

Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System

A NA study of Pleural Effusion, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
6
Study locations

NCT03831386: Recruiting NA study of Pleural Effusion, sponsored by Johns Hopkins University.

NCT03831386 is a NA study of Pleural Effusion that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 200 participants, above the 163-participant average among 6 other Pleural Effusion trials with a reported enrollment target (23% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03831386, a NA study of Pleural Effusion, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
6
Study locations

Study Summary

Malignant pleural effusion remains a debilitating complication of end stage cancer, which can be greatly improved by the introduction of the indwelling tunneled pleural catheter (IPC). However, there is no standard of care regarding drainage and limited data on the utility of different drainage techniques. In addition, many patients develop discomfort and chest pain during drainage. The investigators propose to evaluate gravity drainage and suction drainage on quality of life measures and outcomes.

Primary Outcome

The primary endpoint is the difference between the mean daily change in pain score during IPC drainage via the vacuum bottle technique and IPC drainage via the gravity bag technique over two weeks after IPC placement. Pre-drainage and post-drainage pain scores will be recorded each day of IPC placement. Measurements are in millimeters along a 10 cm VAS. VAS score is a range of 0 to 100. Lower limit is 0, meaning no pain; upper limit is 100, meaning extreme pain.

Conditions Studied

Interventions

  • PROCEDURE Vacuum-Based IPC
  • PROCEDURE Gravity-Based IPC

Study Locations (6)

Illinois

  • Northwest Community Healthcare - Arlington Heights

Maryland

  • Johns Hopkins Hospital - Baltimore

South Carolina

  • Medical University of South Carolina - Charleston

Tennessee

  • Vanderbilt University Medical Center - Nashville

Washington

  • Swedish Medical Center - Seattle

Other

  • University of Oxford - Oxford

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-01-31
Est. Completion 2026-12-31
Phase NA
Johns Hopkins University

1,448 total trials

What NCT03831386 shows while recruiting

NCT03831386 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 6 other Pleural Effusion trials with a reported enrollment target (23% higher).

The record links to 1 condition, with Pleural Effusion appearing as the primary indexed condition, and to 2 interventions - of which Vacuum-Based IPC is the first listed.

NCT03831386 lists 6 locations in 6 states (Illinois, Maryland, South Carolina).

Frequently Asked Questions

What is clinical trial NCT03831386 about?

NCT03831386 is a clinical study titled "Gravity Versus Vacuum Based Indwelling Tunneled Pleural Drainage System". Malignant pleural effusion remains a debilitating complication of end stage cancer, which can be greatly improved by the introduction of the indwelling tunneled pleural catheter (IPC). However, there is no standard of care regarding drainage and limited data on the utility of different drainage tech...

What is the current status of trial NCT03831386?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2019-01-31. Estimated completion is 2026-12-31.

What conditions does trial NCT03831386 study?

This clinical trial studies the following conditions: Pleural Effusion.

What interventions are being tested in trial NCT03831386?

The interventions under investigation include: Vacuum-Based IPC (PROCEDURE), Gravity-Based IPC (PROCEDURE).

Who is sponsoring clinical trial NCT03831386?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03831386 being conducted?

This trial has 6 study locations across Illinois, Maryland, South Carolina, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pleural Effusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03831386, the US trial registry maintained by the National Library of Medicine. NCT03831386 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.